FDA will be establishing the Drug
Supply Chain Security Act (DSCSA) (Title II of Pub. L. 113-54)
Pilot Project Program to implement section 582(j) of the Federal
Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C.
360eee-1). This program will assist the development of the
interoperable electronic system established by 2023.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.